meropenem
J - Antiinfectives For Systemic Use -> J01 - Antibacterials For Systemic Use -> J01D - Other Beta-Lactam Antibacterials -> J01DH - Carbapenems -> J01DH02 - Meropenem
Administration category:
Free
Medicine group:
antibacterial
Brand name:
Meronem
Safety margins
| Weight | ROA | Dosage |
|---|---|---|
|
ROA: iv |
Dosage: min. 500mg 3 dd to max. 2000mg 3 dd |
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: iv | ||||
|
GFR: 30 - 50 |
Interval: 12 Hours |
|||
|
GFR: 10 - 30 |
Dosage: 50% |
Interval: 12 Hours |
||
|
GFR: <10 |
Dosage: 50% |
Interval: 24 Hours |
||
Renal elimination:
60-70%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: 1-2 g per 24 uur in 1-2 doses
Hemo dialysis: Intermitterende hemodialyse: 500mg -1 gram elke 24 uur (op dialysedagen na dialyse toedienen) óf 1-2 gram na dialyse.
CAV / VVHD: 2-4 g per 24 uur in 2-3 doses
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-499320.1
Updated: 07/07/2020 - 14:32
Status: Published